Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trialMan‐Fung Yuen, T. Jesse Kwoh, Jeong-Won Jang et al.|Nature Medicine|2021Cited by 156